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To determine the prognosis of severe heart failure and
its relation to the level of ventricular dysfunction and
ectopic activity, 77 patients with functional class III or
IV heart failure were followed prospectively for 12 ±
11 months (range 5 to 40). Survival was computed using
life-table methods and related to clinical, hemodynamic,
M-mode echocardiographic and 24 hour Holter moni-
toring data. Hemodynamic evaluation invariably re-
vealed pump dysfunction. Holter monitoring showed a
high incidence of ventricular premature depolarizations
which were paired in 62%, multiform in 71%, three or
more consecutive in 51% and five or more in 39%.
Overall survival was 52% at 1 year and 32% at 2
years. Mortality was highest during the initial 4 months,
after which annual mortality averaged 20%. Cardiac
mortality was due equally to sudden death and heart
failure. Cardiac mortality during the first 4 months was
related by univariate analysis to functional class (X2 =
Over the past decade, there has been great interest in iden-
tifying new therapeutic modalities for the treatment of pa-
tients with chronic severe heart failure, Studies in this area
have focused primarily on correcting hemodynamic abnor-
malities and improving the functional capacity of such pa-
tients. In contrast, relatively little attention has been given
to altering survival patterns despite considerable evidence
that patients with severe heart failure have a high annual
mortali ty rate (1-11),
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11.4, P < 0.001) and to the presence of five or more
consecutive ventricular premature depolarizations (X2
= 3.9, p < 0.05) due to a relation between these vari-
ables and nonsudden cardiac death; sudden death was
not related to any initial variable. No variable was re-
lated to cardiac mortality after 4 months. Multivariate
analysis identified only functional class as an indepen-
dent prognostic variable, functional class IV patients
having a 6.8 greater relative risk of nonsudden cardiac
death than functional class III patients. Hemodynamic,
Holter monitoring and echographic measurements pro-
vided no additional prognostic information.
It is concluded that severe heart failure is associated
with a high mortality from both sudden and nonsudden
cardiac death. Cardiac mortality is independently re-
lated to functional status but not to the level of pump
dysfunction, cardiac size or ventricular ectopic activity.
In order to address this issue, it is important that survival
rate and the cause of death in such patients be clarified and
that prognostic factors be identified. In previous studies,
annual mortality rates in patients with heart failure have
ranged between 10% or less on the one extreme (4,12,13)
and between 50 to 59% on the other (1,2,6). Mortality has
been attributed to sudden death in as few as II % of deaths
(2) and in as many as 60 to 90% (1,4), Finally, survival
has been variously correlated with hemodynamic measure-
ments (1,3), ejection fraction (9, II), echocardiographic left
ventricular mass and relative wall thickness (14) and the
extent of ventricular arrhythmias (3,15,16). However, all
of the studies in which such correlations were noted were
retrospective and included many patients with only mild
heart failure or examined only a small number of prognostic
variables, or both.
Accordingly, the present study was undertaken to eval-
uate prospectively: I) the short-term survival rate of patients
with medically refractory heart failure, 2) the cause of death
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in such patients, and 3) the relation between survival and
clinical variables, hemodynamic measurements, left ven-
tricular ejection fraction, left ventricular end-diastolic di-
mension and relative wall thickness and the extent of ven-
tricular arrhythmias observed during 24 hour Holter
recordings.
Methods
Study patients. Seventy-seven patients with New York
Heart Association functional class III or IV chronic heart
failure werestudied. All patients referred between July 1979
and December 1981 for evaluation of vasodilator therapy
were screened. Patients were included in the study if heart
failure was present for 6 months or more, exertion was
limited by fatigue or breathlessness, or both, but not by
angina, and there was no history of myocardial infarction
within 6 months . Patients with mitral stenosis, aortic ste-
nosis, syncope or documented sustained ventricular tachy-
cardia were excluded. All patients were receiving digoxin
and diuretic drugs and all had moderate to severe left ven-
tricular dysfunction as assessed quantitatively by radio-
nuclide angiography or cardiac catheterization (57 patients;
ejection fraction = 27 ± 10%) or qualitatively by two-
dimensional echocardiography.
In 40 patients, heart failure was attributed to coronary
artery disease on the basis of either cardiac catheterization
or the presence of at least two of the following three vari-
ables: 1)priordocumented myocardial infarction, 2)electro-
cardiographic evidence of transmural myocardial infarction,
and 3) major left ventricular regional wall motion abnor-
malities noted on left ventricular angiography, two-dimen-
sional echocardiography or radionuclide ventriculography.
Heart failure was attributed to idiopathic cardiomyopathy
in 28 patients and to chronic aortic or mitral regurgitation
in 9 patients.
Protocol. Afterenrollment in the study, all baseline data
were obtained over a 3 to 5 day period. Functional class
was determined by interviews with the patient and family
and by observing the patient during walking on the level
ground and up two flights of stairs. Right heart catheter-
ization was performed in 75 of the 77 patients to determine
the need for an optimal dose of vasodilator agents. Cathe-
terization was performed with a Swan-Ganz thermodilution
catheter. Baseline measurements of right atrial, right ven-
tricular, pulmonary artery and pulmonary wedge pressures
were made. Thermodilution cardiac output was determined
in triplicate using iced injectate. Hemodynamic responses
to sublingual isosorbide dinitrate and oral hydralazine were
evaluated and a therapeutic regimen recommended.
Twenty-four hour ambulatory electrocardiographic tape
recordings were obtained in all patients. These recordings
were performed using an Avionics 445 recorder and ana-
Iyzed using an Avionics 660A computerized scanner at a
scanning speed of 60 X normal (CardioData Systems). Ar-
rhythmias were printed at a paper speed of 25 mm/s and
analyzed without knowledge of the patient's clinical or
hemodynamic status. Ventricular arrhythmias were classi-
fied according to peak hourly frequency of ventricular pre-
mature depolarizations, their average frequency, their mor-
phologic features and the presence and frequency of couplets,
bigeminy and nonsustained ventricular tachycardia.
M-mode echocardiograms were obtained in all patients
using a commercially available ultrasonoscope. In 72 pa-
tients, tracings were of adequate quality to permit quanti-
tative measurements. The left ventricle was visualized and
recorded at the high chordal level. Left ventricular end-
diastolic dimension and posterior wall thickness were mea-
sured at the peak of the R wave. Echocardiograms were
measured with a digitizer and programmable computer. Three
to five sequential cardiac cycles were measured and the
values averaged. Relative wall thickness was calculated as
2 x posterior wall thickness/left ventricular end-diastolic
dimension (normal = 0.33 ± 0.06 [17)).
Follow-up. All patients received digoxin and diuretic
drugs during the study. Vasodilators were recommended in
most patients but were only taken by 39 patients during the
study; 10 received hydralazine and 29 received isosorbide
dinitrate. The other patients did not receive vasodilators
because of side effects or the decision of the referring phy-
sician. Eleven patients received procainamide or quinidine
during the study. In five patients, antiarrhythmic therapy
was initiated to suppress supraventricular arrhythmias. In
six patients, antiarrhythmic therapy was initiated for control
of asymptomatic ventricular arrhythmias before enrollment
inthestudy; this decision was made bytheattending physician.
After discharge , patients were contacted by telephone at
monthly intervals. The patient's functional status and med-
ical regimen were assessed. In the event of death, infor-
mation regarding the patient's state immediately before death
was gathered from family members , the personal physician
andwitnesses of the terminal event. Deathwascharacterized
as unexpected or due to heart failure. A death was cate-
gorized as sudden if the patient was clinically stable for at
least I week before death and was witnessed to have no
acute cardiac symptoms I hour before death.
Statistical methods. Cumulative survival and mortality
rates were calculated using life-table methods. The relation
of clinical , hemodynamic and Holter variables to mortality
was assessed using both univariate and multivariate ana-
lytical approaches. Both methods of analysis yielded com-
parable results. Noncardiac deaths were treated as "drop-
outs" in the life-table analysis.
Univariate analysis was performed using the Kaplan-Meier
survivorship method (18) Comparison of mortality curves
among patient subgroups was carried out using the WiI-
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coxon-Breslow method (19). For continuous variables,
subgroups were defined by examining the distribution of
variables between survivors and nonsurvivors and identi-
fying the value that best separated the two groups. Alter-
natively, subgroups were defined by values suggested by
prior studies to identify patients at high risk of early mor-
tality. Categories based on continuous variables were as
follows: age of 55 years or less, ejection fraction of 20%
or less, pulmonary wedge pressure of 20 mm Hg or less,
cardiac index of 2.0 liters/min per m2 or less, stroke work
index of less than 30 g-rn/m", left ventricular end-diastolic
dimension of less than 6.0 em, relative wall thickness of
less than 0.35, mean ventricular premature depolarization
rate of 30/hour or less and peak ventricular premature de-
polarization rate of 100/hour or less. Noncontinuous vari-
ables included sex, functional class and the presence or
absence of coronary disease, frequent couplets, multiform
ventricular premature depolarizations, bigeminy and three
or more and five or more consecutive ventricular premature
depolarizations. Frequent couplets were defined as fi ve or
more couplets within 24 hours.
In addition, multivariate analysis was performed using
Cox's regression model for censored survivor data (20).
The relation of mortality to the following variables was
assessed: age, sex, functional class, presence or absence of
coronary artery disease, ejection fraction, pulmonary wedge
pressure, cardiac index, stroke work index, left ventricular
end-diastolic dimension, relative wall thickness, mean and
peak ventricular premature depolarization rates, frequent
couplets, multiform ventricular premature depolarizations,
bigeminy, three and five or more consecutive ventricular
premature depolarizations, treatment with antiarrhythmic
agents and treatment with vasodilators.
Mean data are expressed as mean ± standard deviation.
A probability [p] value of < 0.05 was considered statisti-
cally significant.
Results
Clinical features . Characteristics of the study group are
summarized in Tables I and 2. The mean pulmonary wedge
pressure was 20 ± 8 mm Hg and mean cardiac index 1.9
± 0.5 liters/min per m2 , consistent with the presence of
heart failure. Holter monitoring revealed frequent ventric-
ular premature depolarizations (couplets) which were paired
in 62% of the patients, multiform in 71% and occurred as
three and five or more consecutive ventricular premature
depolarizations in 51 % and 39%, respectively. No patient
exhibited sustained ventricular tachycardia.
Mortality. The meanfollow-up time for the study group
was 12 months (range 5 to 40). During this period of ob-
servation, 50 patients died. Nineteendeaths were classified
as sudden cardiac death, 23 as caused by heart failure, 2 as
unwitnessed cardiac death and 6 as death from noncardiac
causes (cancer in 4, pneumonia in I and stroke in I). Twenty-
four of the cardiac deaths occurred in the hospital.
Cumulative survival rates . For the total patient pop-
ulation, the I year cumulative survival rate was 52% and
the 2 year survival rate was 32% (Fig. I). There was an
initial high mortality rate during the first 4 months; after
this period, the annual mortality rate was approximately
20%. Mortality due to sudden death versus heart failure
occurred with approximately the same incidence and the
same temporal pattern(Fig. 2). Survival patterns for patients
with and without coronary artery disease were comparable
(Fig. 3).
Univariate survival analysis. Cardiac mortality during
the first 4 months after enrollment correlated significantly
with functional class (X2 = 11 .4, P < 0.00I) and the pres-
ence of five or more consecutive ventricular premature de-
polarizations (X2 = 3.9, P < 0.05) (Fig. 4). These two
variables tended to be interrelated, fi ve or more consecutive
ventricular premature depolarizations occurring in 47% of
patients in functional class IV versus 26% of patients in
functional class III (0.05 < p < 0.10). Age, sex, ejection
fraction, hemodynamic data, echocardiographic data and
other Holter monitoring data did not correlate with early
cardiac mortality. No variable correlated with cardiac mor-
tality after the first 4 months.
Functional classandfive or more consecutive ventricular
premature depolarizations also correlated signifi cantly with
nonsudden cardiac mortality within the fi rst 4 months after
enrollment (functional class: X2 = 18.2, P < 0.001 ; five
or more consecutive ventricular premature depolarizations:
X2 = 3.1, 0.05 < P < 0.10). Sex also correlated with
nonsudden cardiac mortality (X2 = 6.4, P < 0.02) with
womenhaving a higher mortality rate than men. No variable
correlated with mortality due to sudden death. However,
after the first 4 months of enrollment, more patients with
heart failure due to coronary artery disease tended to die
suddenly than did patients without coronary artery disease
(Fig. 5).
Multivariate survival analysis. The only variable that
was found to correlate significantly with cardiac mortality
was functional class (estimated coeffic ient = 1.103; P <
0.00I; estimated relative risk = 3.0). This was due to a
correlation between nonsuddencardiac death and functional
class (estimated coeffic ient = 1.914; P < 0.001; estimated
relative risk = 6.8). Functional class did not correlate with
mortality due to sudden death. No other variable correlated
significantly with mortality independent of the relation be-
tween functional class and mortality.
Determinants of early mortality. To identify addi-
tional variables associated with mortality rate within the fi rst
4 months, we compared clinical, hemodynamic, echocar-
diographic and Holter monitoring data from the 24 patients
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Table 1. Clinical Characteristics of the Study Patients
Total Group Cardiac Deaths
Witnessed Cardiac Deaths
(n = 77) (n = 44) Sudden (n = 19) Nonsudden (n = 23)
Demographic
Age (yr) 6 1 :!: II 60 :!: II 55 :!: I I 63 :!: 10
Male 58 (75%) 33 (75%) 18 (95%) 13 (56%)
History
Functional class III 47 (61%) 2 1 (48%) 13 (68%) 8 (35%)
Functional class IV 30 (39%) 23 (52%) 6 (32%) 15 (65%)
Cause of heart failure
Coronary artery disease 40 (52%) 22 (50%) 13 (68%) 7 (30%)
Cardiomyopathy 28 (36%) 15 (34%) 6 (32%) 9 (39%)
Valvular disease 9 (12%) 7 (16%) 0 (0) 7 (30%)
Medications
Digoxin 77 (100%) 44 (100%) 19 (100%) 23 (100%)
Diuretic drugs 77 (100%) 44 (100%) 19 (100%) 23 (100%)
Vasodilators 40 (52%) 26 (59%) 8 (42%) 16 (70%)
Antiarrhythmic agents 11 (14%) 9 (20%) 5 (26%) 4(17%)
Mortality
Occurring ,,;;2 months 20 (45%) 10 (53%) 10 (43%)
from enrollment
Occurring out of hospital 18 (4 1%) 14 (74%) 4 (17%)
who died within this interval with data from the 51 patients
who survived over 4 months. Early mortality was associated
with functional class (Xl = 11.7, P < 0.001) and five or
more consecutive ventricular premature depolarizations (Xl
= 5.9 , P < 0.02). No other variable was significantly
associated with early mortality.
Discussion
Survival patterns in heart failure . Results of the pres-
ent study indicate that chronic severe heart failure due to
either coronary or noncoronary disease is associated with a
high mortality rate. During the first 4 months after enroll-
Table 2. Hemodynam ic and Echocardiographic Data and Results of 24 Ho ur Holter Monitoring in the Study Patien ts
Hemodynamic data
Ejection fraction (%) (n = 57)
PWP (mm Hg) (n = 75)
Cardiac index
(liters/min per nr' )
(n = 75)
Stroke work mdex
(g-m/nr' )
(n = 75)
Echocardiographic data
LV end-diastolic dimension
(cm) (n = 72)
Relative wall thickness
(n = 72)
Holter monitor results
Mean VPD rate
Peak VPD rate
Frequent couplets
Multiform VPDs
Bigeminy
;;. 3 consecutive VPDs
;;. 5 consecutive VPDs
Total Group Cardiac Deaths
Witnessed Cardiac Deaths
(n = 77) (n = 44) Sudden (n = 19) Nonsudden (n = 23)
27 :!: 10 25 :!: 9 24 :!: 8 26 ± 10
20 :!: 8 22 :!: 8 21 ± 8 22 ± 7
1.9 :!: 0 .5 1.8 :!: 0.4 1.8 ± 0.5 1.9 ± 0 .3
24 ± 12 21 :!: 9 20 ± II 22 ± 8
6. 2 ± 1.0 6.3 :!: 1.1 6.2 :!: 0.8 63 ± 1.3
0 .37 :!: 0 .11 0 .37 ± 0 .12 0.34 :!: 0 .06 0.40 ± 0.14
179 ± 345 223 ± 426 327 ± 546 144 ± 306
354 ± 539 394 ± 6 13 556 ± 778 277 ± 446
48 (62%) 30 (68%) 13 (68%) [5 (65%)
55 (7 1%) 30 (68%) II (58%) 18 (78%)
20 (26%) 14 (32%) 6 (32%) 8 (35%)
39 (5 1%) 25 (57%) II (58%) 13 (56%)
26 (34%) 20 (45%) 8 (42%) II (48%)
LV = left ventricular; PWP = pulmonary wedge pressure; VPD = ventricular premature depolarizations.
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Figure 1. Cumulative survival rates for all 77 patients with med-
ically refractory chronic heart failure,
Figure 3. Comparison of cumulative survival rates for patients
with heart failure due to coronary artery disease (CAD) versus
patients with heart failure due to other causes (NON-CAD), Other
abbreviations as in Figure 2,
ment in this study, close to 25% of the patients died, Sub-
sequently, the annual mortality rate was approximately 20%,
Such an initial high mortality rate is characteristic of studies,
such as the present one, in which referral is often due to an
apparent worsening of a patient's clinical status, This in-
dexing technique produces inclusion of a subgroup of pa-
tients with deteriorating cardiac function who may be likely
to die early, Therefore, the mortality rate of chronic stable
heart failure is probably best indicated by the mortality
patterns noted after 4 months, approximately 20% a year.
These findings are similar to those noted by Massie et
al. (I) in a similar group of patients. In a retrospective study
including 57 patients, these investigators observed a 1 year
survival rate of 65% and an 18 month survival rate of 37%,
Patients with stable heart failure before recruitment exhib-
ited a 21 % annual mortality rate, similar to the mortality
rate suggested by our study, whereas patients with pro-
Figure 2. Comparison of cumulativemortalityratesdue to sudden
death versuscongestiveheart failure (CHF). NS = not significant;
p '" probability,
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gressively worsening heart failure had a 45% annual mor-
tality rate,
In contrast to the present study, Massie et al. (I) did not
observe a higher mortality rate at the outset of their study.
This difference is probably related to their patient selection
criteria, They only included patients who were receiving
nitrates or hydralazine and excluded patients with sudden
worsening of heart failure in the 3 months before enrollment;
however, patients with "gradual worsening" over the 3
months before enrollment were included. We elected not to
make such a distinction in the present study because the
definition of gradual versus sudden worsening is somewhat
arbitrary. In our experience, most patients with marked
worsening of chronic heart failure also report that it was
preceded by gradual worsening.
No other studies have been performed specifically in
patients with medically refractory heart failure, However,
prior studies (2-11) in patients with various levels of failure
have revealed annual mortality rates of 10 to 60%. This
wide variability most likely reflects variations in the severity
of the heart failure in the patient populations.
Cause of mortality. Our findings suggest that sudden
death is responsible for approximately half of the overall
mortality in patients with heart failure due to coronary artery
disease. Massie et al. (I) also noted a high incidence of
sudden death in their patients, most of whom had coronary
artery disease. Similar results have been found in studies
of patients with heart failure after myocardial infarction
(21,22),
In our patients with heart failure due to causes other than
coronary disease, sudden death also was a significant prob-
lem, During the first 4 months of follow-up, 20% of the
patients died suddenly. However, subsequently, the inci-
dence of sudden death tended to be less than in patients
with coronary disease. Therefore, sudden death may not be
408 WILSON ET AL
PROGNOSIS IN HEART FAILURE
JACC Vol 2. No 3
September 1983 403-10
p=NS
CAD:
NON-CAD: ---
SUDDEN DEATH
/
/ - - - - - - - -- - - - -
100
N
'-'
s, 80
'-
......
-J
~ 60g;
::t
~ 40
......
'-
'" 20;S
~ I
l.J /
0
0 4 8 12 16 20 24
MONTHS
100 ALL PATIENTS
N
'-'
-J
80
~ FC III......
:::.. 60~
lJ)
~ 40 I V
......
'-
'" e< fJfJ1;S 20s
l.J
0
0 4 8 12 16 20 24
MONTHS
100
N \
'-' \
80 \
-J
\~ , NO VT~5......
:::.. 60
,
s \ VT~5
lJ) \.- ---- '"-_.,~ 40 ._ - - - ,
......
,
'- -,
'" p<.fJ5;S 20s
l.J
a
0 4 8 12 16 20 24
MONTHS
Figure 4. Comparison of cumulative survival rates forpatients in
New York Heart Association functionalclass (FC) III versusfunc-
tional class IV and for patients with and without five or more
consecutive ventricular premature depolarizations (2::5 VT). Sur-
vival was significantly related to both variables , but only during
the first 4 months after enrollment.
as major a problem in stable patients without coronary dis-
ease as in patients with coronary disease.
In prior studies, the cause of death in patients with heart
failure due to congestive cardiomyopathy has been variable.
Hamby et al. (2) reported that only 11% of 35 deaths noted
in 100 patients with cardiomyopathy were sudden. In a
preliminary report, Huang et al. (12) noted no sudden deaths
in 35 patients with cardiomyopathy followed up for a mean
of 22 months. In contrast , Shugoll et al. (4) reported that
four of five deaths in 50 patients with cardiomyopathy were
sudden. Finally, Meinertz et al. (15) followed up 75 patients
with cardiomyopathy for a mean of 10 months; 14 patients
died, 8 from sudden death.
Surviva l: relation to clinical and hemodynamic vari-
ables. The only clinical or hemodynamic variable that was
noted to correlate with survival was functional class; the
risk of nonsudden cardiac mortality within the first4 months
after enrollment was much greater in functional class IV
than functional class III patients. After this initial 4 month
Figure 5. Comparisonofcumulative mortality due to sudden death
for patients with heart failure due tocoronary artery disease (CAD)
versus patients with heart failure due toothercauses. Themortal ity
curves were not significantly different , but suggest a tendency for
patients withoutcoronary artery disease to have a lower mortality
rate due to sudden death 4 months after enrollment in the study.
period, no clinical or hemodynamic variable correlated with
survival. Recent studies (23) suggest that the functional
capacity of patients with heart failure is determined by the
overall severity of circulatory dysfunction. This may explain
why patients with more functional limitation were at a higher
risk of early mortality from heart failure. In contrast, rest
hemodynamic measurements and ejection fraction do not
correlate with cardiac reserve (24,25). This may explain the
failure of these variables to correlate with survival.
In contrast to our findings, Massie et al. (I ) noted a
relation between total cardiac mortality and both rest pul-
monary wedge pressure and rest stroke work index. This
difference between their fi ndings and those in our study may
be due to the retrospective nature of their study, to the
previously noted differences in patient inclusion criteria and
to the methods of analysis. Specifically, the relation of
hemodynamic differences to mortality was evaluated using
analysis of variance, a technique that does not take into
account variable follow-up periods. Our findings also do
not support the suggestion by Benjamin et al. (14) that a
low relative wall thickness portends early mortality.
Survival: relation to Holter monitor variables. Our
patients had an extremely high incidence of complex ven-
tricular arrhythmias. Prior investigators (26,27) also noted
that severe left ventricular dysfunction due to coronary ar-
terydisease is associated with a high incidenceof ventricular
arrhythmias. Our finding that patients with nonischemic heart
failure have a high incidence of ventricular arrhythmias is
not as widely appreciated, although there have been two
preliminary reports (12.13) that ventricular arrhythmias are
frequent in patients with congestive cardiomyopathy.
The frequency and type of ventricular arrhythmias noted
on Holter monitor recording did not correlate with subse-
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quent sudden death. In contrast, the presence of five or
more consecutive ventricular premature depolarizations cor-
related with mortality due to heart failure and occurred more
frequently in functional class IV patient s than functional
class III patients. These findings suggest that the presence
of complex ventricular arrhythmias in patients with severe
heart failure is primarily a reflection of underlying ventric-
ular dysfunction rather than an independent risk factor for
sustained ventricular tachycardia or fibrillation.
The relation of ventricular ectopic activity to cardiac
mortality has not previously been studied prospectively in
patients with medically refractory chronic heart failure .
However, two prospective studies (17,18) of the relation
between ventricular arrhythmia and mortality in patients
with less severe idiopathic cardiomyopathy have been re-
ported in preliminary form . The results of a study by Huang
et al. (12) are consistent with our findings. In 35 patients,
they noted a high incidence of complex ventricular activity
during 24 hour Holter monitoring but no subsequent sudden
death s over a I year follow-up period . In contrast , Meinertz
et al. (15) followed up 75 patients for approximately I year
and noted that sudden death was related to the presence of
more than 20 episodes of ventricular tachycardia in a 24
hour period. The significance of this finding is unclear; we
rarely observed such frequent episodes of ventricular tachy-
cardia in our study group .
Potential limitations. It is possible that the designated
cause of heart failure was incorrect in some of our patients ,
particularly in those who did not undergo coronary an-
giography . Coronary angiography was not performed on
patients unless it was considered necessary for their clinical
care. However, it is unlikely that sufficient patients were
misclassified by diagnosis to have significantly influenced
our results.
It is also possible that inclusion of a larger patient pop-
ulation would have permitted the identification of additional
weak but significant correlations between mortality and ini-
tial variables. However, given the high mortality rate ob-
served during the study, all clinically significant correlations
were probably detected.
A third potential limitation of this study is the admin-
istration of vasodilators or antiarrhythmic therapy , or both ,
to some of the patients . To control completely for these
variables , it would have been necessary to withhold antiar-
rhythmic therap y from all patients and use the same vaso-
dilator agent or agents in all patients. We did not feel that
it was appropriate to discontinue antiarrhythmic therapy,
particularly when utilized to control atrial arrhythmias. In
any event , only a small number of patients received such
agents and exclusion of these patients from analysi s does
not alter the findings of this study. Vasodilators were re-
ceived by a larger number of patients but did not appear to
influence mortality when examined using univariate or mul-
tivariate analysis.
Clinical significance. Most recent interventional studies
in patient s with chronic severe heart failure have focused
primarily on correcting hemodynamic abnormalities and im-
proving functional capacity. The results of this study suggest
that an additional important objective must be to reduce the
extremely high mortality experienced by such patients. In
particular, attention must be given to reducing the incidence
of sudden death. For example, it might be valuable to un-
dertake studies to determine whether invasive electrophys-
iologic evaluation of patients with severe heart failure is
predictive of subsequent sudden death. Studies to determine
if chronic antiarrhythmic therapy reduces mortality in heart
failure would also be useful.
The results of this study also suggest that resting hemo-
dynamic measurements, echographic left ventricular size,
24 hour Holter monitoring and ejection fraction do not pro-
vide useful prognostic information in patients with severe
heart failure . In particular, the presence of complex ven-
tricular arrhythmia during ambulatory electrocardiographic
recordings does not appear to be an independent risk factor
for sudden death . Therefore, the presence or absence of
such arrhythmias probably should not be used to decide
whether antiarrhythmic therapy is indicated in a given patient.
We thank Brenda O. Barnard for her secretarial assistance in prepanng
the manuscnpt.
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